Proper training about injection locations keeps this from happening
AOD-9604 is sent to an independent third-party laboratory for HPLC and Mass Spectrometry analysis before each batch is released
topical) Quality control across retail products varies considerably Not yet FDA-approved as a therapeutic drug in the US Requires guidance from a qualified peptide serum clinic for optimal use How to Use Peptide Serum AOD 9064 Step-by-Step Infographic: How to Use Peptide Serums Correctly HOW TO USE PEPTIDE SERUM AOD 9064 STEP ACTION 1 Cleanse skin thoroughly (pH-balanced cleanser recommended) 2 Apply toner to prep skin barrier 3 Apply 23 drops of AOD 9064 serum to face/target area 4 Gently press (don't rub) into skin using fingertips 5 Wait 6090 seconds for absorption 6 Layer moisturiser on top to seal 7 Apply SPF 30+ in the morning 8 Repeat AM and/or PM daily for best results (812 week cycle recommended) INJECTION PROTOCOL (Clinic-Supervised Only) Dosage: 300mcg 1mg per day (subcutaneous) Timing: 30 mins before exercise OR before bed Cycle: 1216 weeks recommended Always under supervision of a certified clinic Topical Application (Serum Format) Cleanse your face with a gentle, pH-balanced cleanser Apply toner to prep your skin barrier Dispense 23 drops of the serum onto fingertips Press gently into target areas forehead, cheeks, neck Wait 6090 seconds before layering additional products Follow with moisturiser to seal active ingredients in Use SPF 30+ every morning when using any active peptide serum Expert Tip: Peptide serums work best when skin is slightly damp after cleansing
The STEP 4 trial [2] specifically examined weight maintenance after initial weight loss, showing that continued semaglutide treatment maintained weight loss, while participants switched to placebo regained an average of 6.9% of their body weight over 48 weeks (Rubino et al., JAMA, 2021)
Key Highlights AOD9604 activates lipolytic pathways through beta-3 adrenergic receptor upregulation and cAMP-PKA-HSL cascade activation in adipocytes The peptide inhibits acetyl-CoA carboxylase to suppress lipogenesis while promoting fatty acid oxidation in laboratory models Research confirms no IGF-1 stimulation or glucose metabolism disruption, distinguishing it from full-length growth hormone Cartilage studies show proteoglycan synthesis enhancement and improved tissue structure in osteoarthritis animal models What is AOD9604
